KINEVANT SCIENCES
Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs.
KINEVANT SCIENCES
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.kinevant.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Current Employees Featured
Official Site Inspections
http://www.kinevant.com Semrush global rank: 5.8 M Semrush visits lastest month: 1.44 K
- Host name: 131.124.199.104.bc.googleusercontent.com
- IP address: 104.199.124.131
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Kinevant Sciences"
About Us - Kinevant
Kinevant Sciences (kine-a-vant) is a clinical-stage biopharmaceutical company dedicated to treating rare inflammatory and autoimmune diseases with significant unmet need. Our lead …See details»
Kinevant Sciences - Crunchbase Company Profile & Funding
Organization. Kinevant Sciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Kinevant Sciences is a clinical-stage …See details»
Org Chart Kinevant Sciences - The Official Board
Organizational Chart of Kinevant Sciences. Kinevant Sciences www.kinevant.com. has 11 executives - and belongs to Roivant Sciences +1 646 968 4123; Add an executive. Kinevant …See details»
Kinevant Sciences - Org Chart, Teams, Culture & Jobs - The Org
Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs. Industries. Biotechnology, Health Care …See details»
Contact - Kinevant
Kinevant Sciences, Inc. 151 W 42nd Street New York, NY 10036. Email: [email protected]See details»
KINEVANT SCIENCES, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for KINEVANT SCIENCES, INC. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Kinevant Sciences - Contacts, Employees, Board Members
Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs. ... Solutions. Products. Resources. …See details»
Kinevant Sciences - VentureRadar
Kinevant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company developing new medicines for rare autoimmune and inflammatory diseases. The …See details»
Kinevant Sciences - VentureRadar
Kinevant is dedicated to developing innovative therapies for serious inflammatory and autoimmune diseases, with a current focus on creating a new treatment for sarcoidosis. …See details»
Kinevant Sciences Company Overview, Contact Details
Kinevant Sciences is on a mission to transform the lives of people living with rare inflammatory diseases through high-impact medicine. Kine is a word from Ancient Greece meaning “to …See details»
Important Clinical Trial Results Announcement for Sarcoidosis …
Dec 23, 2024 Kinevant is committed to publishing the results of RESOLVE-Lung to inform future sarcoidosis research. “Although RESOLVE-Lung failed to show a treatment benefit for …See details»
Kinevant Sciences - Overview, News & Similar companies - ZoomInfo
Apr 25, 2024 Kinevant Sciences is on a mission to transform the lives of people living with rare inflammatory diseases through high-impact medicine. Kine is a w ord from Ancient Greece …See details»
Kinevant Sciences Employee Directory, Headcount & Staff | LeadIQ
Kinevant Sciences is on a mission to transform the lives of people living with rare inflammatory diseases through high-impact medicine. Kine is a word from Ancient Greece meaning “to …See details»
Careers - Kinevant
If there is a specific business need, our human resource manager will contact external recruiters directly. Kinevant will not be responsible for any fees related to unsolicited resumes. Kinevant …See details»
Kinevant Sciences - YouTube
Kinevant Sciences is developing new therapies for rare inflammatory and autoimmune diseases, initially focusing on sarcoidosis with an anti-GM-CSF monoclonal...See details»
Roivant Ends Lung Drug After Trial | Conexiant
Dec 3, 2024 The company's unit, Kinevant Sciences, said its once-monthly injectable drug, namilumab, failed to meet the main and secondary goals in the study evaluating it in 107 …See details»
Research - Kinevant
Namilumab is an investigational, novel fully human monoclonal antibody conveniently administered once a month as a subcutaneous injection. Namilumab is a potent GM-CSF …See details»
The RESOLVE-Lung Study
This study is no longer enrolling new participants, but we hope you will consider participating in other sarcoidosis clinical trials in the future.See details»
News - Kinevant
Nov 17, 2022 Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis Read More 11.17.2022. …See details»